ConductScience.org, home

Paper2500406

Folinic acid modulation of fluorouracil: tissue kinetics of bolus administration.

Spears CP and 2 others. Invest New Drugs, 1989. Cited by 27 papers, by iCite.

Cite this record

ConductScience Library. Folinic acid modulation of fluorouracil: tissue kinetics of bolus administration. Papers, record 2500406. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2500406

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Folinic acid modulation of fluorouracil: tissue kinetics of bolus administration.
PubMed
Journal
Invest New Drugs
PubMed
Year
1989
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
27
iCite
Relative citation ratio, by iCite
1.13
iCite
Revised in PubMed
2022-12-07
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Spears CPC P
2Gustavsson BGB G
3Frösing RR

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
FluorouracilMajor topic
LeucovorinMajor topic
Aged
Biotransformation
Colonic Neoplasms
Cytosol
Drug Interactions
Female
Fluorodeoxyuridylate
Humans
Lacticaseibacillus casei
Male
Middle Aged
Thymidylate Synthase

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
CA 39629NCI NIH HHSUnited StatesR01CA039629PubMed and NIH

Source NIH RePORTER

Download CSV of grants

References42

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
16164559Selective enhancement of 5-fluorouridine uptake and action in rat hepatomas in vivo following pretreatment with D-galactosamine and 6-azauridine or N-(phosphonacetyl)-L-aspartate.Eur J Cancer (1965)1980https://conductscience.org/library/papers/6164559PubMed
22783153Deoxyuridylate effects on thymidylate synthase-5-fluorodeoxyuridylate-folate ternary complex formation.Biochem Pharmacol1989https://conductscience.org/library/papers/2783153PubMed
33167844Mechanisms of innate resistance to thymidylate synthase inhibition after 5-fluorouracil.Cancer Res1988https://conductscience.org/library/papers/3167844PubMed
45350077Influence of ribose donors on the action of 5-fluorouracil.Cancer Res1969https://conductscience.org/library/papers/5350077PubMed
57449757Activation and protection from 5-fluorodeoxyuridylate inactivation of mammalian thymidylate synthetase by pyridoxal 5'-phosphate.Enzyme1980https://conductscience.org/library/papers/7449757PubMed
621043247Effect of de novo purine synthesis inhibitors on 5-fluorouracil metabolism and cytotoxicity.Biochem Pharmacol1981https://conductscience.org/library/papers/21043247PubMed
74203910Mechanism of interaction of thymidylate synthetase with 5-fluorodeoxyuridylate.Biochemistry1974https://conductscience.org/library/papers/4203910PubMed
86688119Relationship of cellular folate cofactor pools to the activity of 5-fluorouracil.Mol Pharmacol1983https://conductscience.org/library/papers/6688119PubMed
9125086Quenching of thymidylate synthetase fluorescence by substrate analogs.Biochem Biophys Res Commun1975https://conductscience.org/library/papers/125086PubMed
103487626High-dose continuous infusion folinic acid and bolus 5-fluorouracil in patients with advanced colorectal cancer: a phase II study.J Clin Oncol1986https://conductscience.org/library/papers/3487626PubMed
11157805Assay of intracellular free and macromolecular-bound metabolites of 5-fluorodeoxyuridine and 5-fluorouracil.Cancer Res1979https://conductscience.org/library/papers/157805PubMed
126762925Is there a role for thymidine in cancer chemotherapy?Cancer Treat Rev1982https://conductscience.org/library/papers/6762925PubMed
137377545A centrifugal column assay for thymidylate synthetase using the active site titrant 5-fluoro-2'-deoxyuridylate.Anal Biochem1980https://conductscience.org/library/papers/7377545PubMed
146189380Fluorinated pyrimidines and their nucleosides.Adv Enzymol Relat Areas Mol Biol1983https://conductscience.org/library/papers/6189380PubMed
156973389Effect of excess folates and deoxyinosine on the activity and site of action of 5-fluorouracil.Cancer Res1981https://conductscience.org/library/papers/6973389PubMed
163943080Effects of methotrexate on folates in Krebs ascites and L1210 murine leukemia cells.Cancer Lett1986https://conductscience.org/library/papers/3943080PubMed
17147465Cytotoxicity of 5-fluoro-2'-deoxyuridine: requirement for reduced folate cofactors and antagonism by methotrexate.Proc Natl Acad Sci U S A1978https://conductscience.org/library/papers/147465PubMed
186939434Biochemical factors affecting the tightness of 5-fluorodeoxyuridylate binding to human thymidylate synthetase.Biochem Pharmacol1981https://conductscience.org/library/papers/6939434PubMed
196982167The enhancement of 5-fluorouracil anti-metabolic activity by leucovorin, menadione and alpha-tocopherol.Eur J Cancer Clin Oncol1982https://conductscience.org/library/papers/6982167PubMed
20472732Enhanced 5-fluorouracil nucleotide formation after methotrexate administration: explanation for drug synergism.Science1979https://conductscience.org/library/papers/472732PubMed

See all 42 referencesDownload CSV of references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 27 citations.

PMIDTitleJournalYearIn PapersSource
36612253Increasing Dosage of Leucovorin Results in Pharmacokinetic and Gene Expression Differences When Administered as Two-Hour Infusion or Bolus Injection to Patients with Colon Cancer.Cancers (Basel)2022https://conductscience.org/library/papers/36612253PubMed
33613849Folinic acid in colorectal cancer: esquire or fellow knight? Real-world results from a mono institutional, retrospective study.Oncotarget2021https://conductscience.org/library/papers/33613849PubMed
14735184Improved survival in patients with peritoneal metastases from colorectal cancer: a preliminary study.Br J Cancer2004https://conductscience.org/library/papers/14735184PubMed
8027622Adjuvant intraperitoneal 5-fluorouracil and intravenous leucovorin after colorectal cancer surgery: a randomized phase II placebo-controlled study.Int J Colorectal Dis1994https://conductscience.org/library/papers/8027622PubMed
2793368Schedule-dependency of in vivo modulation of 5-fluorouracil by leucovorin and uridine in murine colon carcinoma.Invest New Drugs1989https://conductscience.org/library/papers/2793368PubMed
1764871Pharmacokinetic optimisation of anticancer therapy.Clin Pharmacokinet1991https://conductscience.org/library/papers/1764871PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
TYMS7298PubTator's text mininghttps://conductscience.org/library/genes/7298

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2500406

GET https://conductscience.org/api/papers/v1/2500406/references?page=2